Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 251 | 0 | 0 | 202 | 249 |
| Operating Income | -251 | N/A | N/A | -202 | -249 |
| Interest Expense | 25 | 0 | 0 | 11 | 9 |
| Other Income | -643 | 0 | 0 | -72 | 764 |
| Pre-tax Income | -919 | 0 | 0 | -285 | 506 |
| Net Income Continuous | -919 | N/A | N/A | -285 | 506 |
| Net Income | $-919 | $N/A | $N/A | $-285 | $506 |
| EPS Basic Total Ops | 0.00 | N/A | N/A | -0.05 | 0.10 |
| EPS Basic Continuous Ops | -0.17 | N/A | N/A | -0.05 | 0.09 |
| EPS Diluted Total Ops | 0.00 | N/A | N/A | -0.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.17 | N/A | N/A | -0.05 | 0.09 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.14 | -0.15 | N/A | N/A |
| EBITDA(a) | $-251 | $N/A | $N/A | $-202 | $-249 |